Myocardial phosphoproteomics and single cardiomyocyte force measurements endorse DYRK1A as a candidate therapeutic target for incomplete myocardial reverse remodelling after aortic valve replacement
16 March 2023 (17:30 - 18:30)
Organised by: 
Abstract
17 More presentations in this session
Access the full session
The Event
HFA Winter Research Meeting on Translational Heart Failure 2023
16 March 2023
17:30 CET
You may be interested in
Congress Session
Congress Presentation
Congress Presentation
